
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
DNA Methylation and Expression Profiles of Whole Blood in Parkinson’s Disease
Adrienne Henderson, Qi Wang, Bessie Meechoovet, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 54
Adrienne Henderson, Qi Wang, Bessie Meechoovet, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
N6-methyladenosine and Neurological Diseases
Nan Zhang, Chunhong Ding, Yuxin Zuo, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1925-1937
Closed Access | Times Cited: 102
Nan Zhang, Chunhong Ding, Yuxin Zuo, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1925-1937
Closed Access | Times Cited: 102
One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration
Eirini Lionaki, Christina Ploumi, Nektarios Tavernarakis
Cells (2022) Vol. 11, Iss. 2, pp. 214-214
Open Access | Times Cited: 64
Eirini Lionaki, Christina Ploumi, Nektarios Tavernarakis
Cells (2022) Vol. 11, Iss. 2, pp. 214-214
Open Access | Times Cited: 64
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Epigenetic modification in Parkinson’s disease
Hao Song, Juanli Chen, Jin Huang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
Hao Song, Juanli Chen, Jin Huang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 12
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 12
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
B Whittle, Osagie Izuogu, Hannah Lowes, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
B Whittle, Osagie Izuogu, Hannah Lowes, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease
Paulina González-Latapí, Bernabé I. Bustos, Siyuan Dong, et al.
Annals of Neurology (2024) Vol. 95, Iss. 6, pp. 1162-1172
Open Access | Times Cited: 9
Paulina González-Latapí, Bernabé I. Bustos, Siyuan Dong, et al.
Annals of Neurology (2024) Vol. 95, Iss. 6, pp. 1162-1172
Open Access | Times Cited: 9
Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
Nóra Török, Rita Maszlag-Török, Kinga Molnár, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 35
Nóra Török, Rita Maszlag-Török, Kinga Molnár, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 35
DNA methylation as a mediator of genetic and environmental influences on Parkinson’s disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome
Samantha L. Schaffner, Michael S. Kobor
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 29
Samantha L. Schaffner, Michael S. Kobor
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 29
Multifaceted collagen-DDR1 signaling in cancer
Hua Su, Michael Karin
Trends in Cell Biology (2023) Vol. 34, Iss. 5, pp. 406-415
Closed Access | Times Cited: 18
Hua Su, Michael Karin
Trends in Cell Biology (2023) Vol. 34, Iss. 5, pp. 406-415
Closed Access | Times Cited: 18
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Lipid Metabolism in Cancer: The Role of Acylglycerolphosphate Acyltransferases (AGPATs)
Angeliki Karagiota, Georgia Chachami, Efrosyni Paraskeva
Cancers (2022) Vol. 14, Iss. 1, pp. 228-228
Open Access | Times Cited: 20
Angeliki Karagiota, Georgia Chachami, Efrosyni Paraskeva
Cancers (2022) Vol. 14, Iss. 1, pp. 228-228
Open Access | Times Cited: 20
Non-coding 886 ( nc886 / vtRNA2-1 ), the epigenetic odd duck – implications for future studies
Emma Raitoharju, Sonja Rajić, Saara Marttila
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Emma Raitoharju, Sonja Rajić, Saara Marttila
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive status
Andy Madrid, Ligia A. Papale, Phillip E. Bergmann, et al.
Alzheimer s & Dementia (2025)
Open Access
Andy Madrid, Ligia A. Papale, Phillip E. Bergmann, et al.
Alzheimer s & Dementia (2025)
Open Access
Dual disease co-expression analysis reveals potential roles of estrogen-related genes in postmenopausal osteoporosis and Parkinson’s disease
Dongdong Yu, Jian Kang, Chengguo Ju, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Dongdong Yu, Jian Kang, Chengguo Ju, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson’s disease and insomnia
Xinyu Li, Wen-Kai Yu, Jinghao Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Xinyu Li, Wen-Kai Yu, Jinghao Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Epigenetic Biomarkers Driven by Environmental Toxins Associated with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the United States: A Systematic Review
Melanie Engstrom Newell, Anumitha Aravindan, Ayesha Babbrah, et al.
Toxics (2025) Vol. 13, Iss. 2, pp. 114-114
Open Access
Melanie Engstrom Newell, Anumitha Aravindan, Ayesha Babbrah, et al.
Toxics (2025) Vol. 13, Iss. 2, pp. 114-114
Open Access
Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Weighted 2D-kernel density estimations provide a new probabilistic measure for epigenetic age
Juan-Felipe Perez-Correa, Thomas Stiehl, Riccardo E. Marioni, et al.
Genome biology (2025) Vol. 26, Iss. 1
Open Access
Juan-Felipe Perez-Correa, Thomas Stiehl, Riccardo E. Marioni, et al.
Genome biology (2025) Vol. 26, Iss. 1
Open Access
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives
Adelaida Hernaiz, Janne M. Toivonen, Rosa Bolea, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12609-12609
Open Access | Times Cited: 17
Adelaida Hernaiz, Janne M. Toivonen, Rosa Bolea, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12609-12609
Open Access | Times Cited: 17
Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson’s disease
Samantha L. Schaffner, William Casazza, Fanny Artaud, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Samantha L. Schaffner, William Casazza, Fanny Artaud, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Parkinson’s Disease, Parkinsonisms, and Mitochondria: the Role of Nuclear and Mitochondrial DNA
Andrea Legati, Daniele Ghezzi
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 4, pp. 131-147
Closed Access | Times Cited: 9
Andrea Legati, Daniele Ghezzi
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 4, pp. 131-147
Closed Access | Times Cited: 9
Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson’s disease
Tng J. W. Teddy, Barbara Wing Yan Wong, Esther H. Y. Sim, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Tng J. W. Teddy, Barbara Wing Yan Wong, Esther H. Y. Sim, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Proteomic Analysis of Protective Effects of Dl-3-n-Butylphthalide against mpp + -Induced Toxicity via downregulating P53 pathway in N2A Cells
Yuan Zhao, Jian Zhang, Yidan Zhang, et al.
Proteome Science (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Yuan Zhao, Jian Zhang, Yidan Zhang, et al.
Proteome Science (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Vault RNAs (vtRNAs): Rediscovered non-coding RNAs with diverse physiological and pathological activities
Mahsa Aghajani Mir
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 772-787
Open Access | Times Cited: 6
Mahsa Aghajani Mir
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 772-787
Open Access | Times Cited: 6